Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Cost of Revenue
$305.20M
Quarterly · Period ending: · USD
BIO Cost of Revenue
Latest reported$305.20Mperiod ending
Latest reported$305.20Mperiod ending
BIO Quarterly Cost of Revenue ($0.00 → $305.20M)
Quarterly cost of revenue
High-resolution chart · PNG
BIO cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 85,612,000 | |
| 81,016,000 | |
| 74,482,000 | |
| 73,386,000 | |
| 76,155,000 | |
| 76,032,000 | |
| 86,300,000 | |
| 46,100,000 | |
| 45,000,000 | |
| 50,300,000 | |
| 50,300,000 | |
| 40,300,000 | |
| 43,900,000 | |
| 47,000,000 | |
| 47,600,000 | |
| 40,600,000 | |
| 42,200,000 | |
| 39,500,000 | |
| 47,000,000 | |
| 36,400,000 | |
| 37,800,000 | |
| 42,800,000 | |
| 44,300,000 | |
| 36,000,000 | |
| 37,300,000 | |
| 37,600,000 | |
| 39,200,000 | |
| 32,100,000 | |
| 32,600,000 | |
| 35,100,000 | |
| 38,000,000 | |
| 32,700,000 | |
| 32,800,000 | |
| 30,800,000 | |
| 34,800,000 | |
| 30,100,000 | |
| 29,200,000 | |
| 30,500,000 | |
| 33,200,000 | |
| 29,100,000 | |
| 30,800,000 | |
| 29,000,000 | |
| 32,600,000 | |
| 28,300,000 | |
| 25,900,000 | |
| 26,500,000 | |
| 27,000,000 | |
| 21,900,000 | |
| 24,600,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |